Hokuriku Pharmaceutical (300016.SZ): Glucamine Gadolate approved for marketing

Zhitongcaijing · 07/01 09:57

Zhitong Finance App News, Hokuriku Pharmaceutical (300016.SZ) announced that the company received a notice of approval for the marketing application for the marketing of the chemical ingredient glucamine gadolate issued by the State Drug Administration. The chemical raw material for gadolipic acid glucamine can be used to produce gadolipic acid glucamine injections, which are intravenous contrast agents used in magnetic resonance imaging (MRI).